South Korea · Delayed Price · Currency is KRW Kyongbo Pharmaceutical Statistics
Total Valuation
KRX:214390 has a market cap or net worth of KRW 151.33 billion. The enterprise value is 258.83 billion.
| Market Cap | 151.33B |
| Enterprise Value | 258.83B |
Important Dates
The last earnings date was Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:214390 has 23.91 million shares outstanding. The number of shares has increased by 1.88% in one year.
| Current Share Class | 23.91M |
| Shares Outstanding | 23.91M |
| Shares Change (YoY) | +1.88% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 17.15% |
| Owned by Institutions (%) | 0.20% |
| Float | 9.13M |
Valuation Ratios
The trailing PE ratio is 365.23.
| PE Ratio | 365.23 |
| Forward PE | n/a |
| PS Ratio | 0.62 |
| PB Ratio | 1.07 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 143.48 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.03, with an EV/FCF ratio of -11.70.
| EV / Earnings | 624.68 |
| EV / Sales | 1.06 |
| EV / EBITDA | 13.03 |
| EV / EBIT | 35.46 |
| EV / FCF | -11.70 |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.79.
| Current Ratio | 0.97 |
| Quick Ratio | 0.38 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | 5.27 |
| Debt / FCF | -5.06 |
| Interest Coverage | 2.02 |
Financial Efficiency
Return on equity (ROE) is 0.29% and return on invested capital (ROIC) is 2.23%.
| Return on Equity (ROE) | 0.29% |
| Return on Assets (ROA) | 1.83% |
| Return on Invested Capital (ROIC) | 2.23% |
| Return on Capital Employed (ROCE) | 5.89% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.83 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, KRX:214390 has paid 283.20 million in taxes.
| Income Tax | 283.20M |
| Effective Tax Rate | 40.60% |
Stock Price Statistics
The stock price has decreased by -15.05% in the last 52 weeks. The beta is 1.15, so KRX:214390's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | -15.05% |
| 50-Day Moving Average | 5,286.20 |
| 200-Day Moving Average | 5,757.48 |
| Relative Strength Index (RSI) | 70.34 |
| Average Volume (20 Days) | 108,300 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:214390 had revenue of KRW 243.45 billion and earned 414.34 million in profits. Earnings per share was 17.28.
| Revenue | 243.45B |
| Gross Profit | 90.63B |
| Operating Income | 8.66B |
| Pretax Income | 697.55M |
| Net Income | 414.34M |
| EBITDA | 21.23B |
| EBIT | 8.66B |
| Earnings Per Share (EPS) | 17.28 |
Balance Sheet
The company has 4.40 billion in cash and 111.90 billion in debt, giving a net cash position of -107.50 billion or -4,496.60 per share.
| Cash & Cash Equivalents | 4.40B |
| Total Debt | 111.90B |
| Net Cash | -107.50B |
| Net Cash Per Share | -4,496.60 |
| Equity (Book Value) | 142.02B |
| Book Value Per Share | 5,940.41 |
| Working Capital | -4.42B |
Cash Flow
In the last 12 months, operating cash flow was 1.05 billion and capital expenditures -23.18 billion, giving a free cash flow of -22.12 billion.
| Operating Cash Flow | 1.05B |
| Capital Expenditures | -23.18B |
| Free Cash Flow | -22.12B |
| FCF Per Share | -925.37 |
Margins
Gross margin is 37.23%, with operating and profit margins of 3.56% and 0.17%.
| Gross Margin | 37.23% |
| Operating Margin | 3.56% |
| Pretax Margin | 0.29% |
| Profit Margin | 0.17% |
| EBITDA Margin | 8.72% |
| EBIT Margin | 3.56% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.79%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 0.79% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 288.49% |
| Buyback Yield | -1.88% |
| Shareholder Yield | -1.08% |
| Earnings Yield | 0.27% |
| FCF Yield | -14.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KRX:214390 has an Altman Z-Score of 1.77 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.77 |
| Piotroski F-Score | 5 |